1. Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. (February 2022) Authors: Zhang, Xiu-Ping; Chen, Xiang-Jun; Li, Bo-Zhao; Xu, Shuai; Wu, Zhou-Liang; Hu, Ming-Gen; Zhao, Zhi-Ming; Zhao, Guo-Dong; Wang, Chang-Rong; Hong, Wei; Li, Su-Ping; Li, Lu; Wang, Chun-Gang; Nie, Guangjun; Liu, Rong Journal: Biomaterials Issue: Volume 281(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗